Cargando…

Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance

OBJECTIVE: This study investigates the expression of Lewis y antigen, integrin αv, β3 in epithelial ovarian cancer tissues. We further evaluate the relationship between their expression and chemotherapy resistance of ovarian cancer and its possible clinical significance. METHODS: Tissues of 92 patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jian, Hu, Zhenhua, Liu, Dawo, Liu, Juanjuan, Liu, Chuan, Hou, Rui, Gao, Song, Zhang, Danye, Zhang, Shulan, Lin, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699420/ https://www.ncbi.nlm.nih.gov/pubmed/23725446 http://dx.doi.org/10.1186/1756-9966-32-36

Ejemplares similares

Elevated Levels of Lewis Y and Integrin α(5)β(1) Correlate with Chemotherapeutic Drug Resistance in Epithelial Ovarian Carcinoma
por: Hu, Zhenhua, et al.
Publicado: (2012)

High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian Cancers
por: Hu, Zhenhua, et al.
Publicado: (2013)

Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression
por: Hou, Rui, et al.
Publicado: (2017)

Chemoresistance Is Associated with MUC1 and Lewis y Antigen Expression in Ovarian Epithelial Cancers
por: Zhang, Danye, et al.
Publicado: (2013)

Co-Expression of Lewis y Antigen with Human Epididymis Protein 4 in Ovarian Epithelial Carcinoma
por: Zhuang, Huiyu, et al.
Publicado: (2013)

Study on the Expression and Clinical Significances of Lewis y Antigen and Integrin αv, β3 in Epithelial Ovarian Tumors
por: Wang, Yifei, et al.
Publicado: (2011)

Beclin 1 Expression in Ovarian Tissues and Its Effects on Ovarian Cancer Prognosis
por: Cai, Mingbo, et al.
Publicado: (2014)

The Stimulation of IGF-1R Expression by Lewis(y) Antigen Provides a Powerful Development Mechanism of Epithelial Ovarian Carcinoma
por: Liu, Dawo, et al.
Publicado: (2011)

Lewis y Regulate Cell Cycle Related Factors in Ovarian Carcinoma Cell RMG-I in Vitro via ERK and Akt Signaling Pathways
por: Liu, Dawo, et al.
Publicado: (2012)

Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway
por: Liu, Juanjuan, et al.
Publicado: (2009)

c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer
por: Hao, Yingying, et al.
Publicado: (2017)

Lewis y antigen promotes p27 degradation by regulating ubiquitin-proteasome activity
por: Cai, Mingbo, et al.
Publicado: (2017)

Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I
por: Gao, Lili, et al.
Publicado: (2011)

Lewis (y) Antigen Overexpression Increases the Expression of MMP-2 and MMP-9 and Invasion of Human Ovarian Cancer Cells
por: Yan, Limei, et al.
Publicado: (2010)

Increase in Docetaxel-Resistance of Ovarian Carcinoma-Derived RMG-1 Cells with Enhanced Expression of Lewis Y Antigen
por: Zhang, Fan, et al.
Publicado: (2011)

Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors
por: Liu, Chuan, et al.
Publicado: (2012)

Co-expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis
por: Liu, Juanjuan, et al.
Publicado: (2019)

Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells
por: Zhuang, Huiyu, et al.
Publicado: (2014)

Lewis Y Promotes Growth and Adhesion of Ovarian Carcinoma-Derived RMG-I Cells by Upregulating Growth Factors
por: Li, Feifei, et al.
Publicado: (2010)

Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma
por: WANG, SHENG-TAN, et al.
Publicado: (2011)

Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2015)

Integrin Targeted Delivery of Chemotherapeutics
por: Chen, Kai, et al.
Publicado: (2011)

Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells
por: Zhu, Liancheng, et al.
Publicado: (2014)

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect
por: Liu, Duanyang, et al.
Publicado: (2018)

Regulation of differentiation- and proliferation-inducers on Lewis antigens, α-fucosyltransferase and metastaticotential in hepatocarcinoma cells
por: Liu, F, et al.
Publicado: (2001)

The fucosylated CD147 enhances the autophagy in epithelial ovarian cancer cells
por: Hu, Zhenhua, et al.
Publicado: (2016)

Interaction of CD147 and human epididymis protein 4 promotes invasion and metastasis of ovarian cancer
por: Gao, Lingling, et al.
Publicado: (2021)

Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells
por: LI, FEI-FEI, et al.
Publicado: (2011)

PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells
por: Liu, Hao, et al.
Publicado: (2013)

The Effects of Chemotherapeutics on the Ovarian Cancer Microenvironment
por: Eckert, Mark A., et al.
Publicado: (2021)

Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer
por: Li, Xiaoguang, et al.
Publicado: (2016)

Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling
por: Liu, Huan, et al.
Publicado: (2021)

Systematic Analysis of the Clinical Relevance of Cell Division Cycle Associated Family in Endometrial Carcinoma
por: Zhang, Wenchao, et al.
Publicado: (2020)

Expression of the Carbohydrate Lewis Antigen, Sialyl Lewis A, Sialyl Lewis X, Lewis X, and Lewis Y in the Placental Villi of Patients With Unexplained Miscarriages
por: Ma, Zhi, et al.
Publicado: (2021)

Identification of key genes for guiding chemotherapeutic management in ovarian cancer using translational bioinformatics
por: Yuan, Danni, et al.
Publicado: (2020)

Lewis antigen-negative pancreatic cancer: An aggressive subgroup
por: Liu, Chen, et al.
Publicado: (2020)

HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways
por: Nie, Xin, et al.
Publicado: (2022)

The Roles of Integrin α5β1 in Human Cancer
por: Hou, Jianbing, et al.
Publicado: (2020)

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
por: Gou, Rui, et al.
Publicado: (2022)

Apoptosis of CD19(+) chimeric antigen receptor T cells after treatment with chemotherapeutic agents
por: Yi, Wenfang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u4rqds2mg4q3fh5a6b02vt5hdt